Marc Scheineson is quoted on the Food and Drug Administration’s decision to issue civil money penalties if companies fail to submit their results to the agency’s clinical trials database.
In the News
May 3, 2021
CenterWatch | FDA Issues First-Ever Rebuke to Sponsor for Failing to Submit ClinicalTrials.gov Info
Media Contact